Have any questions? 706-721-6582 or cts@augusta.edu
Study Name | Principal Investigator |
---|---|
(KEYNOTE-641) A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Parikh, Jigarkumar |